Capital International Ltd. CA Purchases 1,337 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Capital International Ltd. CA grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 63,356 shares of the medical equipment provider's stock after buying an additional 1,337 shares during the period. Intuitive Surgical makes up 1.3% of Capital International Ltd. CA's portfolio, making the stock its 18th largest position. Capital International Ltd. CA's holdings in Intuitive Surgical were worth $33,069,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the company. Vanguard Group Inc. increased its holdings in shares of Intuitive Surgical by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after acquiring an additional 360,591 shares in the last quarter. Geode Capital Management LLC raised its holdings in Intuitive Surgical by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock worth $4,039,200,000 after buying an additional 243,802 shares during the period. Fisher Asset Management LLC increased its position in shares of Intuitive Surgical by 1.8% during the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock worth $2,541,356,000 after acquiring an additional 86,488 shares in the last quarter. Norges Bank acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $2,401,493,000. Finally, Invesco Ltd. lifted its position in Intuitive Surgical by 7.7% in the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock valued at $2,165,184,000 after acquiring an additional 295,025 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Analyst Ratings Changes

Several research firms have issued reports on ISRG. Leerink Partners lifted their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Wells Fargo & Company lifted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Evercore ISI lowered their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a report on Wednesday. Finally, Citigroup raised their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research report on Friday, January 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average price target of $602.52.

Insider Activity

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Trading Up 2.7 %

ISRG stock traded up $12.90 during mid-day trading on Wednesday, hitting $491.64. 2,276,380 shares of the company were exchanged, compared to its average volume of 1,602,754. Intuitive Surgical, Inc. has a 1-year low of $367.39 and a 1-year high of $616.00. The stock has a market capitalization of $175.11 billion, a PE ratio of 76.70, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. The business has a 50 day simple moving average of $517.55 and a 200-day simple moving average of $532.24.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. During the same period last year, the firm posted $1.50 EPS. Equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.